By John Harbison|2017-02-22T10:39:52-08:00November 16, 2016|Tech Coast Angels Portfolio Companies in the Press|Comments Off on FDA Grants Orphan Drug Designation to Amplyx Pharmaceuticals for APX001 for Treatment of Multiple Invasive Fungal and Mold Infections
